Literature DB >> 9032202

O2-induced change in ventilation and ventilatory drive in COPD.

C R Dick1, Z Liu, C S Sassoon, R B Berry, C K Mahutte.   

Abstract

We examined the role of respiratory control during O2-induced hypercarbia in patients with chronic obstructive pulmonary disease (COPD), by comparing the observed change in ventilation (delta VEobs) with the delta VE predicted (delta VEpred) from the patients' ventilatory drive and the O2-induced delta PaCO2 and delta SaO2. Eleven stable hypoxemic COPD patients (mean +/- SD: FEV1 = 1.00 +/- 0.25 L, FVC = 2.33 +/- 0.38 L; room air PaCO2 = 52.7 +/- 7.9 mm Hg, SaO2 87.7 +/- 5.1%) were studied. Using standard rebreathing methods, we measured the ventilatory responses to hypercapnia (delta VE/PCO2 = 0.76 +/- 0.55 L/min/mm Hg) and to hypoxia (delta VE/delta SaO2 = -0.74 +/- 0.31 L/min/%). After breathing 100% O2 for 15 min, the mean delta VEobs was -0.08 +/- 0.62 (SEM) L/min (p = NS), the delta SaO2 was 7.6 +/- 3.6% (p < 0.001), and the delta PaCO2 was 6.6 +/- 3.3 mm Hg (p < 0.001). The delta VEpred was expressed as the sum of a decrease in ventilation due to suppression of hypoxic drive [calculated as the product (delta VE/SaO2) x delta SaO2] and an increase in ventilation due to the O2-induced hypercarbia [calculated as the production (delta VE/delta PCO2) x delta PaCO2]. The mean delta VEpred [-0.96 +/- 0.68 (SEM)] did not differ significantly from mean delta VEobs. We conclude that the O2-induced delta VEobs is equal to that expected from the ventilatory drives and the changes in PaCO2 and SaO2; and that O2-induced hypercarbia does not indicate a failure of respiratory control mechanisms in the maintenance of PaCO2 homeostasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032202     DOI: 10.1164/ajrccm.155.2.9032202

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Randomized controlled trial of high concentration oxygen in suspected community-acquired pneumonia.

Authors:  Meme Wijesinghe; Kyle Perrin; Bridget Healy; Mark Weatherall; Richard Beasley
Journal:  J R Soc Med       Date:  2012-04-24       Impact factor: 5.344

Review 2.  Oxygen: kill or cure? Prehospital hyperoxia in the COPD patient.

Authors:  A New
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

Review 3.  Acute cardiopulmonary failure from sleep-disordered breathing.

Authors:  Gordon E Carr; Babak Mokhlesi; Brian K Gehlbach
Journal:  Chest       Date:  2012-03       Impact factor: 9.410

Review 4.  Balancing the risks and benefits of oxygen therapy in critically III adults.

Authors:  G R Scott Budinger; Gökhan M Mutlu
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

5.  [Non-invasive mechanical ventilation in COPD].

Authors:  G-C Funk
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-15       Impact factor: 0.840

6.  High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1).

Authors:  Ariel Jaitovich; Martín Angulo; Emilia Lecuona; Laura A Dada; Lynn C Welch; Yuan Cheng; Galina Gusarova; Ermelinda Ceco; Chang Liu; Masahiko Shigemura; Esther Barreiro; Cam Patterson; Gustavo A Nader; Jacob I Sznajder
Journal:  J Biol Chem       Date:  2015-02-17       Impact factor: 5.157

7.  The effect of high concentration oxygen therapy on PaCO2 in acute and chronic respiratory disorders.

Authors:  Janine Pilcher; Kyle Perrin; Richard Beasley
Journal:  Transl Respir Med       Date:  2013-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.